Regulation of Tumor Vascular Microenvironment by Nestin and Fms-related Tyrosine Kinase ۱ (FLT۱) and Their Prognostic Significance in Renal Cell Carcinoma
محل انتشار: فصلنامه آسیب شناسی ایران، دوره: 19، شماره: 3
سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 86
فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJP-19-3_010
تاریخ نمایه سازی: 14 مهر 1403
چکیده مقاله:
Background & Objective: Hypervascularity is a characteristic feature of renal cell carcinoma (RCC) and microvessel density (MVD) predicts tumor metastasis. Nestin is a stem cell marker that is expressed in proliferating endothelial cells and newly formed vessels and Fms-related tyrosine kinase ۱ (FLT۱) is a proangiogenic factor. This study aimed to evaluate the expression of Nestin and FLT۱ in RCC and their prognostic impact. Methods: This retrospective study included sixty cases of RCC after obtaining ethical approval. Sections were immunohistochemically stained by Nestin and FLT۱ then their expressions were compared to different clinicopathological parameters. MVD was evaluated using Nestin and CD۳۴ and compared to the different parameters. Results: Nestin was expressed mainly in endothelial cells of small vessels in ۶۵% of cases while FLT۱ was expressed in tumor and endothelial cells in ۷۳.۳% of cases. Their expressions were significantly associated with aggressive tumor parameters including larger tumors, high-grade tumors, wider tumor extension, and advanced stage. Moreover, Nestin expression was significantly associated with metastasis. MVD evaluated by Nestin showed more associations with larger tumors, high-grade tumors, wider tumor extension, advanced stage, and metastasis than MVD measured by CD۳۴. Nestin and FLT۱ positivity and high MVD measured by Nestin were significantly associated with short overall survival. Conclusion: Nestin and FLT۱ expressions in RCC may be associated with aggressive tumor features and short patients’ overall survival. MVD evaluated by Nestin may be correlated with tumor progression and metastasis. Nestin and FLT۱ may be used as prognostic biomarkers in RCC.
نویسندگان
Noha Elkady
Department of Pathology, Faculty of Medicine, Menoufia University, Shibin Elkom, Egypt
Reham Abdelaziz
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Menoufia University, Egypt
Rasha Abdelmoneum
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Menoufia University, Egypt
Ahmed Ghonaimy
Department of Urology, Faculty of Medicine, Menoufia University, Shibin Elkom, Egypt
Dina Allam
Department of Pathology, Faculty of Medicine, Menoufia University, Shibin Elkom, Egypt
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :